AI assistant
Sending…
Biofrontera Inc. — Director's Dealing 2022
May 26, 2022
35198_dirs_2022-05-26_6bdd4621-8857-4229-9d5f-770fdb6999be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2022-05-18
Reporting Person: Weber Kevin Daniel (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | Employee stock option (right to buy) | $2.61 | A | 22000 | Acquired | 2032-05-18 | Common Stock (22000) | Direct |
Footnotes
F1: The option vests in three equal annual installments beginning on May 18, 2023.